Janssen\'s Balversa becomes first FDAapproved FGFR kinase inhibitor for advanced BladderCancer httpbit.ly2UBpUiXÂ cancer pharmapic.twitter.comQRfl9hpk1x
Janssen's Balversa becomes first FDA-approved FGFR kinase inhibitor for advanced #BladderCancer http://bit.ly/2UBpUiX #cancer #pharmapic.twitter.com/QRfl9hpk1x
More From BioPortfolio on "Janssen's Balversa becomes first FDA-approved FGFR kinase inhibitor for advanced #BladderCancer http://bit.ly/2UBpUiX #cancer #pharmapic.twitter.com/QRfl9hpk1x"